Primary Site >> Colorectal Cancer

Gene >> DLL1

Journal: Onkologie. 2006 Dec;29(12):563-7.
Title: Gefitinib in combination with 5-fluorouracil (5-FU)/folinic acid and irinotecan in patients with 5-FU/oxaliplatin- refractory colorectal cancer: a phase I/II study of the Arbeitsgemeinschaft fur Internistische Onkologie (AIO).
Author: Hofheinz, Ralf-Dieter|Kubicka, Stefan|Wollert, Jorg|Arnold, Dirk|Hochhaus, Andreas
PMID: 17202826
Journal: Int J Mol Med. 2006 Apr;17(4):681-5.
Title: Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells.
Author: Katoh, Masuko|Katoh, Masaru
PMID: 16525728
Journal: Int J Oncol. 2007 Jan;30(1):247-51.
Title: Notch signaling in gastrointestinal tract (review).
Author: Katoh, Masuko|Katoh, Masaru
PMID: 17143535
Journal: Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):748-55.
Title: Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancer.
Author: Aristu, Jose Javier|Arbea, Leire|Rodriguez, Javier|Hernandez-Lizoain, Jose Luis|Sola, Jesus Javier|Moreno, Marta|Azcona, Juan Diego|Diaz-Gonzalez, Juan Antonio|Garcia-Foncillas, Jesus Miguel|Martinez-Monge, Rafael
PMID: 18164861
Journal: Onkologie. 2010;33(3):89-93.
Title: Gefitinib in combination with capecitabine as second-line therapy in patients with advanced colorectal cancer (aCRC): a phase I/II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Author: Trarbach, Tanja|Reinacher-Schick, Anke|Hegewisch-Becker, Susanne|Vanhoefer, Udo|Frieling, Thomas|Lehnert, Lasse|Schmiegel, Wolff|Graeven, Ullrich
PMID: 20215798
Journal: Exp Cell Res. 2011 Jun 10;317(10):1368-81.
Title: The Notch ligand Delta-like 1 integrates inputs from TGFbeta/Activin and Wnt pathways.
Author: Bordonaro, Michael|Tewari, Shruti|Atamna, Wafa|Lazarova, Darina L
PMID: 21473864
Journal: Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Apr;15(4):396-9.
Title: [Expression of JAG1 and DLL1 genes in colorectal cancer and its clinical significance].
Author: Jin, Hei-ying|Xu, Jun-hua|Wang, Xiao-feng|Ding, Yi-jiang
PMID: 22539391
Journal: Cell Cycle. 2012 Dec 1;11(23):4323-7.
Title: Epigenetic silencing of Notch signaling in gastrointestinal cancers.
Author: Piazzi, Giulia|Bazzoli, Franco|Ricciardiello, Luigi
PMID: 23085543
Journal: Cancer Chemother Pharmacol. 2013 Feb;71(2):321-30.
Title: A phase I trial of imatinib in combination with mFOLFOX6-bevacizumab in patients with advanced colorectal cancer.
Author: Michael, M|Zalcberg, J|Gibbs, P|Lipton, L|Gouillou, M|Jefford, M|McArthur, G|Copeman, M|Lynch, K|Tebbutt, N C
PMID: 23108698
Journal: Oncotarget. 2013 Nov;4(11):1948-62.
Title: Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1.
Author: Francipane, Maria Giovanna|Lagasse, Eric
PMID: 24185040
Journal: Radiother Oncol. 2013 May;107(2):184-8.
Title: Phase I trial of the combination of the Akt inhibitor nelfinavir and chemoradiation for locally advanced rectal cancer.
Author: Buijsen, Jeroen|Lammering, Guido|Jansen, Rob L H|Beets, Geerard L|Wals, Jaap|Sosef, Meindert|Den Boer, Marien O|Leijtens, Jeroen|Riedl, Robert G|Theys, Jan|Lambin, Philippe
PMID: 23647753
Journal: Ann Surg Oncol. 2013 Jul;20(7):2180-7.
Title: A phase I trial of isolated hepatic perfusion (IHP) using 5-FU and oxaliplatin in patients with unresectable isolated liver metastases from colorectal cancer.
Author: Magge, D|Zureikat, A H|Bartlett, D L|Holtzman, M P|Choudry, H A|Beumer, J H|Pingpank, J F|Holleran, J L|Strychor, S|Cunningham, D E|Jones, H L|Zeh, H J 3rd
PMID: 23575907
Journal: Invest New Drugs. 2015 Feb;33(1):187-93.
Title: A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory metastatic colorectal cancer.
Author: Bendell, Johanna C|Jones, Suzanne F|Hart, Lowell|Spigel, David R|Lane, Cassie M|Earwood, Chris|Infante, Jeffrey R|Barton, John|Burris, Howard A
PMID: 25335932
Journal: Oncoimmunology. 2015 Dec 21;5(4):e1101205.
Title: Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients.
Author: Correale, Pierpaolo|Botta, Cirino|Martino, Elodia Claudio|Ulivieri, Cristina|Battaglia, Giuseppe|Carfagno, Tommaso|Rossetti, Maria Grazia|Fioravanti, Antonella|Guidelli, Giacomo Maria|Cheleschi, Sara|Gandolfo, Claudia|Carbone, Francesco|Baldari, Tatiana C
PMID: 27141384
Journal: Anticancer Drugs. 2017 Jun;28(5):531-539.
Title: Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus.
Author: Yang, Bin|Huang, Can-Ze|Yu, Tao|Zhou, Sheng-Ning|Liu, Qi|Liu, Gao-Jie|Chen, Shuang|Han, Fang-Hai
PMID: 28177944
Journal: Cell Commun Signal. 2017 Jun 21;15(1):24.
Title: Kaiso differentially regulates components of the Notch signaling pathway in intestinal cells.
Author: Robinson, Shaiya C|Klobucar, Kristina|Pierre, Christina C|Ansari, Amna|Zhenilo, Svetlana|Prokhortchouk, Egor|Daniel, Juliet M
PMID: 28637464
Journal: Sci Rep. 2018 Jun 13;8(1):9032.
Title: Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer.
Author: Chattopadhyay, Arnab|Yang, Xinying|Mukherjee, Pallavi|Sulaiman, Dawoud|Fogelman, Hannah R|Grijalva, Victor|Dubinett, Steven|Wasler, Tonya C|Paul, Manash K|Salehi-Rad, Ramin|Mack, Julia J|Iruela-Arispe, M Luisa|Navab, Mohamad|Fogelman, Alan M|Reddy, Sriniv
PMID: 29899427